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Background: Hospital associated infections are major problems, which are increasing in incidence and very costly.
However, most research has focused only on measuring consequences associated with the initial hospitalization.
We explored the long-term consequences of infections in elderly Medicare patients admitted to an intensive care
unit (ICU) and discharged alive, focusing on: sepsis, pneumonia, central-line-associated bloodstream infections
(CLABSI), and ventilator-associated pneumonia (VAP); the relationships between the infections and long-term
survival and resource utilization; and how resource utilization was related to impending death during the
follow up period.
Methods: Clinical data and one year pre- and five years post-index hospitalization Medicare records were
examined. Hazard ratios (HR) and healthcare utilization incidence ratios (IR) were estimated from state of the art
econometric models. Patient demographics (i.e., age, gender, race and health status) and Medicaid status (i.e., dual
eligibility) were controlled for in these models.
Results: In 17,537 patients, there were 1,062 sepsis, 1,802 pneumonia, 42 CLABSI and 52 VAP cases. These subjects
accounted for 62,554 person-years post discharge. The sepsis and CLABSI cohorts were similar as were the
pneumonia and VAP cohorts. Infection was associated with increased mortality (sepsis HR = 1.39, P < 0.01; and
pneumonia HR = 1.58, P < 0.01) and the risk persisted throughout the follow-up period. Persons with sepsis and
pneumonia experienced higher utilization than controls (e.g., IR for long-term care utilization for those with sepsis
ranged from 2.67 to 1.93 in years 1 through 5); and, utilization was partially related to impending death.
Conclusions: The infections had significant and lasting adverse consequences among the elderly. Yet, many of
these infections may be preventable. Investments in infection prevention interventions are needed in both
community and hospitals settings.
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Pneumonia and sepsis are major problems, which are in-
creasing in incidence, especially among the elderly [1-4].
Indeed, it has been estimated that approximately 10% of
all intensive care unit (ICU) patients have severe sepsis
on admission or during their ICU stay [5]. Further, des-
pite technological advances in prevention, there has
been no change in the relative risk of inpatient mortality
from such infections in recent years [6]. Infections* Correspondence: ps2024@columbia.edu
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reproduction in any medium, provided the orgenerate a substantial economic toll. For example, re-
cently, in surgical patients the extra inpatient hospital
costs of pneumonia and sepsis were estimated to be
$32,900 and $46,400 respectively [7]. However, this re-
search focused only on measuring the costs associated
with the initial hospitalization.
There is increasing interest in the long-term outcomes
associated with sepsis and pneumonia, although research
in this area is limited [8,9]. In a recent systematic review,
23 studies examining mortality after hospital discharge
with diagnosis of sepsis were found [10]; and, only two
of the studies followed patients for up to five years and
included measures of healthcare utilization [11,12]. The. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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sepsis had ongoing mortality up to 2 years and they
encouraged researchers to include longer-term end-
points. The evidence of the long-term consequences
associated with pneumonia is even sparser. In a single-
site study, researchers examined long-term mortality
after hospitalization with pneumonia [13]. In this investi-
gation, the researchers followed 457 patients after an
index hospitalization for pneumonia and found poor
long-term survival. We could identify no studies of the
long-term clinical consequences of healthcare associated
infections.
To assess the potential value of infection prevention
initiatives in hospital and community settings within a
business-case analysis framework, a better understand-
ing of the long-term clinical and economic consequences
of these infections is necessary [14]. Hence, the aim of
this study was to examine in Medicare patients admitted
to an ICU and discharged alive: the relationships be-
tween sepsis, pneumonia, central-line-associated blood-
stream infections (CLABSI), and ventilator-associated
pneumonia (VAP); the relationships between the infec-
tions and long-term survival and resource utilization;
and to determine how much of the resource utilization
was related to impending death during the follow up
period.Methods
Data sources
We analyzed a unique longitudinal national dataset ini-
tially created to study predictors of healthcare associated
infections in elderly Medicare recipients during a
hospitalization in an ICU [15,16]. In that study, 31 hos-
pitals belonging to the Centers for Disease Control and
Prevention’s (CDC) National Nosocomial Infections Sur-
veillance system that had conducted device-associated
infection surveillance in 2002 were recruited. We
obtained Medicare claims data for the universe of elderly
patients in the participating hospitals during the months
that surveillance was conducted. This study was
approved by the Institutional Review Boards at the
Columbia University Medical Center and the RAND
Corporation.
From this sample we defined “index ICU stays” as
those that occurred during a period of CDC infection
surveillance in 2002. An individual patient could con-
tribute more than one index ICU stay to the sample as
long as the additional ICU stay was in a month in which
surveillance occurred. We merged these index ICU data
with individual Medicare inpatient, outpatient and de-
nominator data for the years 2001 through 2007, yield-
ing a minimum of one year of data prior to, and up to
five years of data following, the index ICU stay. Allanalyses that follow are conditional on being discharged
alive from the index stay.Measures
Exposure
For each index ICU stay, we obtained sepsis and pneu-
monia status from the Medicare claims data and health-
care associated infections status from the CDC data. We
defined exposure variables based on infection status dur-
ing the index hospitalization including: 1) sepsis, 2)
pneumonia, 3) CLABSI and 4) VAP. The fifth group was
the control (i.e., none of these infections).
The definitions of sepsis and pneumonia were based
on the International Classification of Diseases, Ninth Re-
vision, Clinical Modification [ICD-9-CM] codes asso-
ciated with the index ICU stay. Codes used for sepsis
included ICD-9-CMs: 038 (septicemia), 995.91 (sepsis),
995.92 (severe sepsis), and 785.2 (septic shock), and for
pneumonia, ICD-9-CMs: 482.0-482.2, 482.4-482.9
(pneumonia cases with a bacterial diagnosis code) [17].
These ICD-9-CM codes have been used in previous re-
search and the 038 codes for septicemia and the 482
codes for pneumonia have been validated with a specifi-
city and positive predictive value of 99% and 89%, and
99% and 85%, respectively [3,7,18].
Patients with either of the two device-associated infec-
tions of interest (CLABSI and VAP) were identified by
the hospitals’ infection preventionists and reported into
CDC’s system. All infection preventionists used the same
direct surveillance protocols developed by the CDC and
these protocols included both clinical and laboratory
data [19]. In the infection groups, if a person was identi-
fied with a CLABSI, they were not included in the sepsis
group, and similarly, if they were identified with a VAP
they were not included in the pneumonia group. How-
ever, a patient could be identified in both the sepsis and
pneumonia cohorts, or in both the VAP and CLABSI
cohorts.Outcomes
The principal outcome measures were survival and
healthcare utilization. We used the date of death and the
date of discharge from the index admission to define the
length of survival. We used place and date of service to
define healthcare utilization categories, including in-
patient admissions, outpatient visits, emergency depart-
ment admissions, long-term care admissions, and home
healthcare visits. The broad outpatient visits category
included office, outpatient hospital, ambulatory surgical
center, federally qualified health center, state or local
public health clinic, rural health clinic, and community
mental health center visits. For each utilization category
we generated annual counts (365-day period) for each of
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charge date.
Covariates
For each patient, both inpatient and outpatient Medicare
data were used to generate measures of health status
based on 30 aggregated condition codes and 184
hierarchical condition codes using the DxCG software
[20-22]. These controls were calculated based on health-
care experiences during the year prior to the index admis-
sion. Our method used diagnostic information associated
with prior hospitalizations, outpatient, and ambulatory
services to characterize health status by considering
multiple coexisting medical conditions and creating more
aggregated groupings. The hierarchies served to 1) im-
prove clinical validity (e.g., it is not useful to characterize a
person with a more severe manifestation of diabetes
the same as a less serious type); 2) overcome some of
the limitations found in Medicare data due to coding
practices (e.g., the proliferation of recorded diagnoses for
the purpose of maximizing reimbursement); and 3) im-
prove the precision of the risk adjustment [23,24]. We also
included other patient demographics (age, gender, race)
and Medicaid status (i.e., dual eligibility).
Statistical analysis
For each subgroup, summary statistics were computed.
Pearson’s Chi squared statistics or Fisher’s exact test sta-
tistics were used to test the equivalence of categorical
variables. For continuous variables, t-tests or non-
parametric tests were computed.
Mortality models
Patient survival outcomes across infection groups were
examined first by calculating Kaplan-Meier survival
functions and log-rank tests to detect differences among
cohorts. We then estimated multiple variable Cox pro-
portional hazard models to control for the effects of
health status (aggregated condition codes and/or hier-
archical condition codes measures) and other covariates.
We tested the proportional hazard assumption by esti-
mating alternative specifications that admitted interac-
tions between analysis time and variables of interest.
Finally, we estimated multiple variable parametric hazard
models with continuous time frailty to account for un-
observed heterogeneity in health status among subjects
[25,26]. We considered alternative distributional
assumptions for the parametric duration dependence
(exponential, gamma, Gompertz, log logistic, log normal,
and Weibull), selecting Weibull because of model fit and
because it best matched the patterns of duration de-
pendence identified by the Kaplan-Meier models. We
considered gamma and inverse Gaussian distributions tomodel unobserved frailty, and selected the gamma distri-
bution based on model performance.
Utilization models
The data were organized so that the unit of analysis was
the person-year. We formulated multiple variable Pois-
son and negative binomial models for each healthcare
utilization category; however, in the likelihood ratio test
of over-dispersion the alphas were significantly different
from zero, which led us to reject the Poisson models for
the negative binomial models in every case.
Each subject could contribute up to five years of
follow-up or until death. Subjects who died were at risk
for healthcare utilization only for the part of the year in
which they were alive. We defined an exposure variable
to adjust these observations for the amount of time at
risk during the year of death. Variation in time at risk is
typically handled by including ln(exposure) as a variable
in the model and restricting its coefficient to one, typic-
ally referred to as fitting exposure time as an offset. We
refer to this specification as Model 1, which estimates
the full relationship between infection and utilization
but treats censoring (time at risk) as random.
Because the censoring (exposure) was a function of
death, and since death is undoubtedly correlated with
healthcare utilization, the censoring is unlikely to be
random. To determine how much of the resource
utilization was related to impending death during the
follow up period, we admitted an additional polynomial
to account for changes in utilization as a function of
“time-until-death” and identify this specification as
Model 2 (see Additional file 1 for full discussion). In
Model 2, alternative specifications of the “time-until-
death” included step, linear, quadratic, or third order
functions. We also allowed for alternative periods for the
“time-until-death” including 6 months, 12 months, or
24 months prior to death. The Model 2 specifications,
therefore, separately identify an underlying pattern of
utilization following discharge and an additive compo-
nent based on the time until death following discharge.
Huber-White sandwich estimators are used to calculate
all standard errors [27,28].
Results
Thirty-one hospitals from across the United States con-
tributed data on 17,537 subjects who were discharged
alive from 51 ICUs. The majority of the hospitals were
large (median number of beds = 360), teaching (n = 24,
71%) hospitals, which was similar to the overall sample
of CDC National Nosocomial Infections Surveillance
system hospitals at the time.
Table 1 provides an overview of the sample, these sub-
jects accounted for 62,554 person-years post discharge.
There were 1,062 cases of sepsis, 1,802 cases of
Table 1 Sample characteristics
Variables No infection Sepsis Pneumonia CLABSI VAP Between group difference
(N = 14894) (N = 1062) (N = 1802) (N = 42) (N = 52)
Age (mean) 73.84 74.14 73.93 72.64 74.92
Female (%) 48.60 49.90 50.30 57.10 36.50
Race
White (%) 88.80 86.60 * 87.60 90.50 88.50
Black (%) 8.20 10.40 * 9.00 9.50 9.60
Other (%) 3.10 3.00 3.40 0.00 1.90
Dual Eligible (%) 16.30 21.30 ** 23.10 ** 21.40 11.50 ††
No. ACCs (mean) 4.75 5.75 ** 5.10 ** 5.67 ** 4.89 ††
Days alive during follow-up (mean) 1246 1 869 3 ** 877 3 ** 883 8 ** 937 1 * ††
Inpatient admissions (mean)
Year 1 1.19 1.45 ** 1.35 ** 1.64 1.40 ††
Year 2 0.87 1.10 ** 1.13 ** 0.88 0.63 ††
Year 3 0.81 0.88 0.96 ** 1.40 1.04 †
Year 4 0.78 0.80 0.93 ** 0.94 0.68
Year 5 0.73 0.74 0.86 * 0.50 0.86
Outpatient visits (mean)
Year 1 16.65 13.12 ** 12.94 ** 13.02 12.89 ††
Year 2 15.85 13.87 ** 14.30 ** 12.96 13.10 ††
Year 3 15.77 14.59 14.12 ** 14.90 12.41 ††
Year 4 15.49 14.49 13.70 ** 12.47 12.46 †
Year 5 14.92 13.41 13.83 12.94 11.19
Emergency Department visits (mean)
Year 1 1.33 1.53 * 1.44 1.19 1.39
Year 2 1.13 1.39 1.34 * 0.46 0.57
Year 3 1.09 1.24 1.14 1.25 1.22
Year 4 1.10 1.08 1.12 1.06 0.59
Year 5 1.04 0.98 1.08 0.50 0.76
Long-term care admissions (mean)
Year 1 2.18 5.04 ** 3.93 ** 4.43 4.04 ††
Year 2 1.62 3.89 ** 3.17 ** 2.58 2.13 ††
Year 3 1.68 3.87 ** 2.94 ** 2.50 3.93 ††
Year 4 1.88 3.39 ** 3.76 ** 3.35 4.18 ††
Year 5 1.90 3.60 ** 2.98 ** 5.69 * 4.05 ††
Home care visits (mean)
Year 1 0.34 0.60 ** 0.40 0.36 0.23
Year 2 0.29 0.67 ** 0.45 1.50 * 0.40 ††
Year 3 0.26 0.60 ** 0.47 ** 0.60 0.11 ††
Year 4 0.31 0.73 ** 0.50 * 0.06 0.00 ††
Year 5 0.30 0.64 ** 0.39 0.00 0.10
ACC – aggregate condition codes; Sepsis – community or healthcare-associated sepsis, excluding CLABSI; Pneumonia – community or healthcare-associated
pneumonia, excluding VAP; CLABSI – central-line associated blood stream infection; VAP – ventilator associated pneumonia; Comparison between the control
group and an infection group: * p < 0.05; **p < 0.01; Overall test between all groups: †p < 0.05; ††p < 0.01.
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Figure 1 Kaplan-Meier survival functions of three patient
cohorts. An overall log-rank test showed that the survivor functions
differed across patient cohorts (p < 0.01); the survival of the no-
infection group was longer than that of the sepsis group (p < 0.01)
and the pneumonia group (p < 0.01).
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309 patients were identified in both the sepsis and pneu-
monia groups; and 6 patients were identified in both the
CLABSI and VAP groups. Because CLABSI and VAP
were relatively rare, the associated multiple variable
results are only reported in Additional file 2: Table S2.
The mean age was 74 years, with no significant vari-
ation across infection groups. There were slightly more
males than females in the sample but infection status
was not associated with gender. The sample was largely
white, with just over 8% black and 3% other race.
Sepsis was more likely to occur in blacks than whites
(P < 0.05), but race was not associated with other infec-
tion types. The sample was restricted to subjects who
were covered by Medicare, but about 17% of the sample
was also eligible for Medicaid (dual eligible). Dual eligi-
bility was strongly associated with infection (P < 0.01),
with these individuals over-represented in the sepsis and
pneumonia groups. The mean number of aggregated
condition codes during the year prior to the index ICU
admission was nearly 5, with strong associations be-
tween the number of aggregated condition codes and in-
fection status. Those with pneumonia or sepsis had
significantly higher mean aggregated condition codes
than those in the control group (all P values less than
0.01).
Survival following discharge from the index admission
varied substantially among the different cohorts (P <
0.01); the mean number of days alive was substantially
lower in each infection group (range 869 to 937 days)
than in the control group (1246 days) with all P values
less than 0.05. Diagnosis of sepsis and pneumonia were
associated with increased inpatient admission, emer-
gency care, long-term care, and home healthcare use,
along with reduced rates of outpatient visits compared
to no infection. For sepsis, the associations with long-
term care and home healthcare were particularly large
and lasting. The positive association between pneumonia
and inpatient admissions was also persistent throughout
the five-year study period.
Survival models
Figure 1 presents a graph of the Kaplan-Meier survivor
functions by group. The figure shows excess mortality
associated with each infection category over the five-
year period following discharge from the index admis-
sion. The log-rank tests indicated that: 1) overall survival
differed by infection group (P < 0.01) and 2) in pair-wise
comparisons, the control group differed from both sepsis
and pneumonia groups (P < 0.01 in each case).
Table 2 presents the results of the multiple variable
Cox proportional hazard and parametric frailty models.
Tests of the proportional hazard assumption showed
that the relationships of sepsis and pneumonia were notproportional. Thus, the models included interactions
between sepsis and pneumonia and survival, distinguish-
ing the first year post-discharge from the rest of the
follow-up period. The results changed very little with al-
ternative parametric specifications of either duration de-
pendence or frailty (see Additional file 2: Table S2).
Although unobserved frailty was present (P < 0.01), the
results of the relationships between infection type and
survival varied little in the two specifications, so we de-
scribe only results from the Weibull frailty model below.
Infection was associated with increased mortality (sepsis
HR = 1.39, P < 0.01; pneumonia HR = 1.58, P < 0.01). The
relationships were similar for sepsis and CLABSI as well
as pneumonia and VAP (see Additional file 2: Table S2).
There was increased mortality risk associated with sepsis
and pneumonia in the year following discharge (HR rela-
tive to other years = 1.17, P < 0.05 for pneumonia
and 1.11, P = 0.11 for sepsis), and the risk persisted
throughout the entire five-year follow-up period. The
risk of dying among females was lower than among
males (HR = 0.89, P < 0.01). There was no difference in
survival by race, but there was a strong positive gradient
with age. In addition, patients with dual eligibility had a
greater risk of mortality (HR = 1.22, P < 0.01).
Utilization models
Table 3 presents estimation results for the negative bino-
mial models (see Additional file 2: Table S2 for full
utilization models including CLABSI and VAP). We
found that sepsis was significantly related to increased
hospital admissions in years 1 and 2 (IR = 1.40 and 1.17,
respectively) and emergency department visits in year 1
(IR = 1.28); however, these results were no longer signifi-
cant once we accounted for utilization related to death
(Model 2). Sepsis had a large and persistent relationship
with long-term care utilization (IR ranged from 2.67 to
Table 2 Cox proportional hazard and frailty models, post discharge survival




Hazard ratio 95 % CI P Value Hazard ratio CI P Value
Infection (reference = No Infection)
Sepsis 1.36 1.20-1.54 <0.01 1.39 1.22-1.59 <0.01
Sepsis x Year 1 1.21 1.04-1.42 0.02 1.17 1.00-1.37 0.05
Pneumonia 1.55 1.42-1.70 <0.01 1.58 1.42-1.76 <0.01
Pneumonia x Year 1 1.15 1.02-1.30 0.02 1.11 0.98-1.25 0.11
Sepsis & Pneumonia 0.66 0.55-0.80 <0.01 0.66 0.55-0.80 <0.01
Gender (reference =Male)
Female 0.89 0.85-0.94 <0.01 0.89 0.85-0.94 <0.01
Race (reference =White)
Black 1.04 0.96-1.13 0.33 1.04 0.96-1.13 0.34
Other 0.96 0.84-1.09 0.49 0.95 0.84-1.08 0.46
Age Group (reference < 50)
50 to 64 1.76 1.49-2.08 <0.01 1.75 1.48-2.07 <0.01
65 to 74 2.07 1.77-2.41 <0.01 2.06 1.76-2.41 <0.01
75 to 84 3.12 2.67-3.64 <0.01 3.10 2.64-3.64 <0.01
85 to 94 5.25 4.47-6.16 <0.01 5.21 4.36-6.21 <0.01
95 and above 8.38 6.68-10.52 <0.01 8.26 6.47-10.55 <0.01
Insurance (reference = non Medicaid)
Medicaid 1.22 1.14-1.30 <0.01 1.22 1.14-1.30 <0.01
Number of subjects 17537 17537
Number of failures 9694 9694
Log pseudolikelihood −89334.21 −26182.6
Tests of the Cox proportional hazards assumption showed that the effects of sepsis and pneumonia were not proportional over time. Thus, interactions between
sepsis and pneumonia and analysis time (distinguishing the first year after discharge from the rest of the study period) were incorporated into the model. These
analyses controlled for healthcare-associated infections and full results are shown in Additional file 2: Table S2.
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present in Model 2. Sepsis had a similar relationship
with home healthcare utilization, with the exception of
the first year post discharge. The relationship between
sepsis and outpatient visits was in the opposite direction;
that is, in Model 1 sepsis was related to decreased
outpatient visits in year 1 (IR = 0.94, P < 0.05) and this
relationship was present in Model 2 for years 1 and 2
(IR = 0.91 and 0.91, all P values less than 0.05).
The relationships between pneumonia and healthcare
utilization were similar to those of sepsis with a few not-
able differences. In Model 1, pneumonia was associated
with increased hospital admissions until year 4 (IRs 1.24
to 1.30, all P values less than 0.01) and emergency de-
partment visits until year 3 (IRs 1.18 to 1.29, all P values
less than 0.05); however, similar to sepsis, these associa-
tions were not significant in Models 2. Similar to sepsis,
pneumonia had a strong relationship with long-term
care admissions in year 1 (IR = 2.16, P < 0.01) and this
persisted until year 4 (IR = 1.89, P < 0.01); these relation-
ships were also significant in Model 2 for years 1, 2 and4 (all P values less than 0.01). Pneumonia was also asso-
ciated with increased home healthcare visits in year 3
(Model 1, IR = 1.80; Model 2 IR = 1.72, P values ≤ 0.01).
The relationships between sepsis and pneumonia and
inpatient admissions are illustrated in Figures 2A and
2B, respectively. These figures highlight the importance
of increased mortality in the relationship between sepsis
and inpatient admissions, and the modest direct associ-
ation that remained after controlling for utilization
related to death.
Discussion
Previous estimates of the consequences associated with
pneumonia and sepsis have focused mainly on immedi-
ate consequences of infection such as inpatient costs
and short term mortality; and, previous investigators
have not teased out the proportion of utilization asso-
ciated with death. This rigorous econometric study used
a large, comprehensive dataset to examine the relation-
ships between these infections and five-year mortality and
healthcare utilization. Furthermore, our specifications
Table 3 Utilization models for sepsis and pneumonia
IR Sepsis IR Pneumonia
Model 1 IR Model 2 Model 1 IR Model 2
P P P P
Inpatient Admissions
Year 1 1.40 <0.01 1.07 0.12 1.30 <0.01 1.01 0.68
Year 2 1.17 0.04 1.06 0.42 1.25 <0.01 1.09 0.06
Year 3 1.07 0.50 0.97 0.67 1.26 <0.01 1.08 0.15
Year 4 0.95 0.64 0.92 0.40 1.24 <0.01 1.09 0.17
Year 5 1.00 0.99 0.89 0.21 1.12 0.17 1.11 0.20
Outpatient Visits
Year 1 0.94 0.05 0.91 0.01 0.95 0.03 0.94 0.01
Year 2 0.92 0.07 0.91 0.05 0.96 0.24 0.94 0.04
Year 3 0.98 0.68 0.96 0.50 1.00 0.93 0.99 0.68
Year 4 0.95 0.39 0.97 0.55 0.94 0.13 0.94 0.11
Year 5 0.93 0.27 0.95 0.37 0.95 0.25 0.95 0.24
Emergency Department Visits
Year 1 1.28 <0.01 0.97 0.50 1.29 <0.01 1.00 0.94
Year 2 1.13 0.15 1.01 0.85 1.17 0.01 0.99 0.84
Year 3 1.19 0.10 1.06 0.48 1.18 0.02 1.02 0.66
Year 4 0.98 0.87 0.97 0.74 1.10 0.21 0.93 0.20
Year 5 0.95 0.62 0.94 0.41 1.02 0.85 0.92 0.16
Long-term Care Visits
Year 1 2.67 <0.01 2.15 <0.01 2.16 <0.01 1.62 <0.01
Year 2 2.01 <0.01 2.29 <0.01 1.71 <0.01 1.50 <0.01
Year 3 1.81 <0.01 2.20 <0.01 1.60 <0.01 1.24 0.09
Year 4 1.63 0.01 1.86 <0.01 1.89 <0.01 1.50 0.01
Year 5 1.93 <0.01 1.97 <0.01 1.14 0.49 1.16 0.41
Home Care Visits
Year 1 1.26 0.33 1.41 0.22 1.33 0.09 1.35 0.08
Year 2 2.15 0.01 2.02 0.02 1.39 0.10 1.35 0.16
Year 3 1.96 0.05 2.37 0.02 1.80 0.01 1.72 0.01
Year 4 2.22 0.01 2.74 <0.01 1.54 0.07 1.49 0.10
Year 5 2.27 0.02 2.51 0.01 1.41 0.17 1.40 0.15
In Models 1, censoring for the amount of time at risk during year of death is treated as random. In Models 2, an additional polynomial was admitted to account
for changes in utilization as a function of “time-until-death”. All models are negative binomials; standard errors are calculated with Huber-White sandwich
estimators.
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lying utilization as well as the effects of infection on
utilization related to death.
We found large and statistically significant increases in
mortality associated with sepsis and pneumonia. Perhaps
not surprisingly, these mortality effects were largest in
the first year following an ICU stay in which the diagno-
sis of infection was made compared with subsequent
years. Although the effects were persistent both for
pneumonia and sepsis, they were larger over time for
pneumonia. In our analyses, we used extensive controlsfor pre-admission comorbid conditions, conditional on
being discharged alive from the index hospitalization, as
well as models that accounted for unobserved frailty
among subjects. We also controlled for other known
measureable covariates such as gender, age and dual eli-
gibility for Medicare and Medicaid. It may be that des-
pite our state-of-the-art risk adjustment, those with
pneumonia were frailer or it may be related to persistent
physiologic changes associated with pneumonia. Yende
et al. examined 1-year and 5-year mortality in 106
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Figure 2 Inpatient admission incidence ratios associated with infections. Incidence ratios associated with (A) pneumonia and (B) sepsis are
shown. Model 1 estimates the full relationship between infection and utilization but treats censoring (time at risk) as random. Model 2 separately
identifies an underlying pattern of utilization following discharge and an additive component based on the time until death following discharge.
It admits a polynomial to account for changes in utilization as a function of time until death.
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that persist beyond recovery, possibly due to increased
cytokines or persistent abnormalities in the innate im-
mune response [8]. However, the mechanism underlying
the larger, persistent long-term mortality effect related
to pneumonia relative to sepsis is unclear.
We found significant increases in inpatient admissions
in the first two years after infection for those with sepsis
and for the first 4 years for those with pneumonia. This
was due, however, to the association between infection
and mortality. There was very little direct relationship
between infection and downstream utilization after con-
trolling for the time until death, suggesting that excess
utilization manifested in those that eventually died;nevertheless, the indirect association between infection
and healthcare utilization was large. Not surprisingly, we
found very similar results with respect to emergency de-
partment visits.
The relationships between outpatient visits and infec-
tions were different from those of inpatient admissions
and emergency department visits. We found no evidence
of increases in outpatient admissions with or without
controlling for the time until death. Indeed, we found
limited evidence that outpatient visits were negatively
associated with infections within 2 years of discharge
from the index admission. There were, however, very
large and lasting increases in long-term care admissions
and home healthcare visits associated with sepsis and
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http://www.biomedcentral.com/1472-6963/12/432pneumonia, even after accounting for the role of death.
These results are particularly important because of their
magnitude and because of the high costs of long-term
care. For example, individuals were approximately twice
as likely to be admitted to long-term care in each of the
five years following sepsis after controlling for utilization
associated with death. These results, combined with
those of the inpatient admissions models, indicate that
infections have important long-term economic conse-
quences in addition to the increased immediate costs.
We found no evidence that the long-term conse-
quences of CLABSI differed from sepsis, nor evidence
that the long-term consequences of VAP differed from
pneumonia, either with respect to mortality or
utilization. While these results may have important
implications, they are based on relatively few VAP and
CLABSI cases and may be imprecise. Previous research
in this area is sparse. Similar to our results, in one other
study with a relatively small sample size (178 hospital-
associated methicillin-resistant Staphylococcus aureus
[MRSA] bloodstream infections compared to 19
community-associated MRSA bloodstream infections)
investigators found no differences in one year mortality
between the two groups [29]. However, in another study,
patients surviving discharge and categorized as having
hospital-associated pneumonia (n = 66) were at greater
risk of dying than those with community-associated
pneumonia (n = 210) [13]. Clearly, more research is
needed in this area, especially with the occurrence of an
increasing number of community-associated infections
as well as the national healthcare priority of reducing
the high cost, high morbidity and mortality problem of
healthcare associated infections [6,8,30].
This study has a number of strengths and limitations.
The most important concern is that the associations
may not be causal, but rather due to unobserved health
status or severity of illness that is positively associated
with the risk of infection and the outcomes (mortality
and utilization). This concern is mitigated by several fac-
tors. First, the sample consisted only of elderly indivi-
duals who were admitted to an ICU, and our utilization
models were estimated on a sample that included only
those individuals who were discharged alive from the
index ICU stay. Using a comparison group from the
same population increases the homogeneity of the sam-
ple and ensures conservative findings (that is, a bias to-
ward the null), particularly if there is a healthy survivor
effect that reduces the frailty of those who survived
among the infection groups versus those who survived
among the controls. Second, we had access to a unique
dataset that allowed us to follow elderly ICU patients
over five years and obtain utilization data to develop
state-of-the art health status controls for the period
prior to the index hospitalization, and we admitted avariety of specifications of these health status controls
into our models. Third, we estimated survival models
that admitted unobserved frailty. Fourth, we are only
studying those admitted to an ICU, and the long-term
effects of those hospitalized with an infection compared
to a community (non-hospitalized) control group may
actually be greater; that is, our use of ICU patients with-
out infections as controls is likely to bias the analysis to-
wards the null representing a conservative estimate of
these effects.
We found the results to be substantively unchanged
under a variety of risk adjustment specifications, includ-
ing ones that controlled for the full set of 184 hierarch-
ical condition codes, and alternative specifications that
included the number of hierarchical condition codes and
aggregated condition codes of each subject. We also
found little evidence of frailty in the survival models
after admitting the hierarchical condition codes or
aggregated condition codes health status controls.
Nevertheless, though our results are suggestive, they
should be viewed as associations, and causal interpreta-
tions should be made with caution.
Although we estimated models for a number of long-
term healthcare utilization categories, our outcomes
were limited to those measures available in the Medicare
files. There were no data on patient out-of-pocket costs
or quality of life. These data are needed to understand
fully the burden of these infections from a societal
perspective.Conclusions
We found that all infections studied had significant and
lasting adverse consequences. Yet, many of these infec-
tions may be preventable. As we have identified the sig-
nificant long-term health and healthcare utilization
consequences of sepsis and pneumonia, these estimates
should be included in future public health decision mak-
ing in regards to investments in infection prevention
interventions both in the community and hospitals.Additional files
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